I am proud to have represented physicians for more than 25 years. My father is a retired physician and I have the greatest respect for the profession and its practitioners. Unfortunately, over the past 10-years or so, I have seen many... Read More
At the end of 2019, Prime Therapeutics, LLC (“Prime”) announced that it had entered into a three-year supply chain agreement with Express Scripts, Inc. (“ESI”) “to focus on enhancing pharmacy networks and pharmaceutical manufacturer... Read More
While many employers feel confident that their written agreements with employees are enforceable, the drafting or method of delivery of those agreements may ultimately render them unenforceable, leaving the employee without the benefit of its... Read More
In an industry where supply chains are closely monitored, patient data is king, and complex medications require high-touch services by distribution partners, biologics and pharmaceutical manufacturers have turned to specialty... Read More
The impact of Direct and Indirect Remuneration ("DIR") fees on the specialty pharmacy industry cannot be overstated and has been widely reported in White Papers and industry news reports. However, the impact of DIR fees on the 340B sector is only... Read More
Over the past several months, a new brand of marketing has emerged in the compound pharmacy space, shifting from marketing aimed at prescribing physicians, to direct-to-consumer marketing of compounded pain creams. Using telemarketing techniques or... Read More
